SCHEMBL6957243

SCHEMBL6957243

CCN1c2ncc(COc3cc[n+]([O-])cc3)cc2C(=O)N(C)c2ccc(F)nc21

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.54
CYP2C9 P11712 5/20 0.54
CYP2C19 P33261 5/20 0.54
CYP1A2 P05177 3/20 0.54
CYP2D6 P10635 2/20 0.38
PARK7 Q99497 1/20 0.33
GRM5 P41594 2/20 0.33
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
CHRM5 P08912 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6960265 0.92 CYP3A4 (0.55) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6954001 0.91 CYP3A4 (0.63) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6965315 0.89 CYP3A4 (0.43) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6955343 0.88 CYP3A4 (0.58) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6953433 0.88 CYP3A4 (0.56) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6959417 0.85 CYP3A4 (0.53) CYP3A4CYP2C9CYP2C19CYP1A2GRM5
SCHEMBL6959409 0.83 CYP3A4 (0.53) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6960694 0.82 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6954865 0.81 CYP3A4 (0.57) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6955968 0.80 CYP3A4 (0.62) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0767172-B1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 2003-03-26 EP claimed
EP-0767172-A1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1997-04-09 EP claimed
EP-0767172-B1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 2003-03-26 EP disclosed
US-5705499-A VIRICIDES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1998-01-06 US disclosed
EP-0767172-A1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1997-04-09 EP disclosed